| | | Index Performance | | Index | Sensex | Nifty | | Open | 13,768.79 | 3,990.15 | | High | 13,971.82 | 4,011.45 | | Low | 13,763.39 | 3,969.65 | | Today's Cls | 13,860.52 | 3,983.40 | | Prev Cls | 13,871.71 | 3,988.80 | | Change | -11.19 | -4.40 | | % Change | -0.08 | -0.14 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | Sobha Developers | 1,094.00 | 6.78 | | Welspun Gujarat | 106.45 | 6.45 | | JB Chemical | 101.95 | 4.89 | | Ipca Lab | 616.15 | 4.26 | | Wyeth | 524.40 | 4.17 | | Losers | | IndusInd Bank | 53.60 | -4.71 | | Reliance Comm | 447.15 | -3.79 | | Maruti Udyog | 935.60 | -3.31 | | GTL | 149.10 | -3.18 | | M&M | 896.50 | -3.16 | | | Market Statistics | | - | BSE | NSE | | Advances | 1,636 | 764 | | Declines | 997 | 626 | | Unchanged | 41 | 17 | | Volume(Nos) | 30.26cr | 34.00cr | | | | | | Market Commentary | | | Market slips amid volatility | | The market ended in the red amid an intra-day swing of 209 points. | | The market continued to witness strong volatile moves as the key indices kept swinging between positive and negative zones throughout the session. | | | The Sensex began the trading session with a negative gap of 103 points. The market moved into positive territory on substantial buying support that propelled the index to an intra-day high of 13972. The index drifted into the red once again in the afternoon to touch the day's low of 13763. After witnessing an intra-day swing of 209 points the Sensex closed at 13861, down 11 points. The Nifty was down five points at 3983.
The market breadth was positive. Of the 2,672 stocks traded on the BSE, 1,630 stocks advanced, 998 stocks declined and 44 stocks ended unchanged. In a volatile market, the BSE Oil & Gas index rose 1.30% while the BSE PSU index, the BSE Bankex, the BSE CD index and the BSE Metal index ended with steady gains. However the BSE Auto index shed 1.51%. | | | Movers & Shakers | - Unity Infraprojects notched up gains on signing a 50:50 joint venture deal with BSEL Infrastructure Realty Ltd for a hotel on a build, operate and transfer basis at Balewadi, Pune.
- Dabur Pharma gained on reports that the company has launched Nanoxel--a novel drug delivery system for the widely used anti-cancer drug Paclitaxel.
- Biocon moved up on signing a MOU with Neopharma to establish a joint venture to manufacture and market a range of bio-pharmaceuticals.
| | | |
Dragging down the market, Reliance Communication shed 3.79% at Rs447, Maruti dipped 3.31% at Rs936, Gujarat Ambuja lost 3.12% at Rs138, Hindalco tumbled 2.17% at Rs171, Dr Reddy’s was down 2.06% at Rs809 and ITC closed weaker by 2.01% at Rs166. L&T, ACC, Tata Motors, Wipro, Reliance Energy, Hero Honda and Bajaj Auto were down 1% each. However, ONGC advanced 2.43% at Rs896 and ICICI Bank was up 2.24% at Rs910. HDFC, Grasim and HLL ended with gains of 1% each.
Over 22.15 lakh ITC shares changed hands on the BSE followed by Welspun Gujarat (20.02 lakh shares), Sobha Developers (17.32 lakh shares), Reliance Capital (14.93 lakh shares) and Sterlite Biotech (12.95 lakh shares).
Sobha Developers was the most actively traded counter on the BSE with a turnover of Rs185 crore followed by HDFC Bank (Rs139 crore), Reliance Industries (Rs121 crore), Reliance Capital (Rs110 crore) and ICICI Bank (Rs86 crore).
| | | | | | | | European Indices at 15:44 IST on 05-01-2007 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 Index | 6276.50 | -10.50 | -0.17 | | CAC 40 Index | 5561.30 | -13.26 | -0.24 | | DAX Index | 6644.90 | -29.50 | -0.44 | | | | | | | | | | | Asian Indices at close on 05-01-2007 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 17091.59 | -262.08 | -1.51 | | Hang Seng Index | 20211.28 | 185.70 | 0.93 | | Kospi Index | 1385.76 | -11.53 | -0.83 | | Straits Times Index | 3029.04 | 5.24 | 0.17 | | Jakarta Composite Index | 1832.55 | 8.45 | 0.46 | | | | | | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com
| |
No comments:
Post a Comment